SABAG MARK (See "Remarks") sold 80.4% of their position (216.89K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $6.23M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/11/2025ACC: 0001193125-25-315923
Officer· See "Remarks"
Since Mar 2026
-216.89K
Net shares
Net seller
$6.23M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
118.72K acquired · 335.62K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+118.72K
Price / share
$18.61
Trade value
$2.21M
% of position
78.6%
12/9/2025
151K→269.72K
Ordinary Shares
Direct
Shares
−118.72K
Price / share
$28.75
Trade value
$3.41M
% of position
44.0%
12/9/2025
269.72K→151K
Ordinary Shares
Direct
Shares
−98.17K
Price / share
$28.70
Trade value
$2.82M
% of position
65.0%
12/9/2025
151K→52.83K
Total
Net shares
−98.17K
Net value
-$4.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/9/2025 | M · Option Exercise | +118.72K | $18.61 | $2.21M | 78.6% | 151K | 269.72K |
| Ordinary Shares Direct | 12/9/2025 | S · Sale | −118.72K | $28.75 | $3.41M | 44.0% | 269.72K | 151K |
| Ordinary Shares Direct | 12/9/2025 | S · Sale | −98.17K | $28.70 | $2.82M | 65.0% | 151K | 52.83K |
| Total | −98.17K | -$4.02M | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Ordinary Shares
118.72K shares
Shares
−118.72K
Strike price
18.61
Held after
0.00
Exercisable
—
12/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Ordinary Shares118.72K shares | 12/9/2025 | M · Option Exercise | −118.72K | 18.61 | — | 0.00 |